This is a nonrandomized Phase II pilot protocol to determine the feasibility, toxicity and disease control (local control, overall and progression-free survival) using hypofractionated preoperative radiation therapy in patients with primary localized soft tissue sarcomas (STS).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Local Disease Control Assessed by Physical Examination
Timeframe: 2 Years
Local Disease Control Assessed by Magnetic Resonance Imaging (MRI)
Timeframe: 2 years